HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elective amputation of the toes in severe lymphedema of the lower leg: rationale and indications.

Abstract
Entry lesions at the toes interdigital spaces, in the setting of chronic lymphedema, are strongly associated with repetitive infective episodes which cause significant morbidity. A prospective study was designed to evaluate the outcome in 2 groups of patients affected by end stage III lymphedema of the lower extremity, treated with the Charles procedure with or without simultaneous amputation of the toes. At a mean 3 years of follow-up, 20% of the patients receiving elective toes amputation experienced recurrence of the infection and none required more proximal amputations. Among the patients not desiring elective toes amputation; 83% suffered multiples attacks of cellulitis and in 88% the toes were eventually amputated. The difference in the number of infective episodes between the 2 groups was highly significant. No cases of recurrent lymphedema were registered. Elective toes amputation in combination with the Charles procedure reduces recurrent cellulitis and long-term morbidity in stage III lymphedema of the lower leg.
AuthorsHung-Chi Chen, Bahar Bassiri Gharb, Christopher J Salgado, Antonio Rampazzo, Enny Xu, Stefano Spanio di Spilimbergo, Syi Su
JournalAnnals of plastic surgery (Ann Plast Surg) Vol. 63 Issue 2 Pg. 193-7 (Aug 2009) ISSN: 1536-3708 [Electronic] United States
PMID19593107 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Amputation, Surgical (methods)
  • Cellulitis (surgery)
  • Female
  • Humans
  • Lymphedema (surgery)
  • Male
  • Middle Aged
  • Prospective Studies
  • Recurrence
  • Reoperation
  • Toes (surgery)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: